293 related articles for article (PubMed ID: 34051400)
1. Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018-2019).
Pfaller MA; Huband MD; Flamm RK; Bien PA; Castanheira M
J Glob Antimicrob Resist; 2021 Sep; 26():117-127. PubMed ID: 34051400
[TBL] [Abstract][Full Text] [Related]
2.
Pfaller MA; Huband MD; Flamm RK; Bien PA; Castanheira M
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182527
[TBL] [Abstract][Full Text] [Related]
3. Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020).
Pfaller MA; Huband MD; Rhomberg PR; Bien PA; Castanheira M
Antimicrob Agents Chemother; 2022 Nov; 66(11):e0102822. PubMed ID: 36286491
[TBL] [Abstract][Full Text] [Related]
4.
Pfaller M; Huband M; Bien PA; Carvalhaes CG; Klauer A; Castanheira M
Antimicrob Agents Chemother; 2024 Feb; 68(2):e0113223. PubMed ID: 38205999
[TBL] [Abstract][Full Text] [Related]
5.
Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
[TBL] [Abstract][Full Text] [Related]
6. Manogepix (APX001A) Displays Potent
Arendrup MC; Jørgensen KM
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366708
[TBL] [Abstract][Full Text] [Related]
7. Manogepix (APX001A)
Arendrup MC; Chowdhary A; Jørgensen KM; Meletiadis J
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32660998
[TBL] [Abstract][Full Text] [Related]
8. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
9. Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
Pfaller MA; Carvalhaes C; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015043
[TBL] [Abstract][Full Text] [Related]
10.
Zhu Y; Kilburn S; Kapoor M; Chaturvedi S; Shaw KJ; Chaturvedi V
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32839219
[TBL] [Abstract][Full Text] [Related]
11. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
[TBL] [Abstract][Full Text] [Related]
12.
Jørgensen KM; Astvad KMT; Arendrup MC
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513793
[TBL] [Abstract][Full Text] [Related]
13. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
[TBL] [Abstract][Full Text] [Related]
14. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
[TBL] [Abstract][Full Text] [Related]
15. Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections.
Castanheira M; Messer SA; Jones RN; Farrell DJ; Pfaller MA
Int J Antimicrob Agents; 2014 Oct; 44(4):320-6. PubMed ID: 25129315
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020).
Carvalhaes CG; Klauer AL; Rhomberg PR; Pfaller MA; Castanheira M
J Clin Microbiol; 2022 Apr; 60(4):e0244921. PubMed ID: 35249367
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
Pfaller MA; Messer SA; Jones RN; Castanheira M
J Antibiot (Tokyo); 2015 Sep; 68(9):556-61. PubMed ID: 25899126
[TBL] [Abstract][Full Text] [Related]
18. Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections.
Shaw KJ; Ibrahim AS
J Fungi (Basel); 2020 Oct; 6(4):. PubMed ID: 33105672
[TBL] [Abstract][Full Text] [Related]
19. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp.
Trzoss M; Covel JA; Kapoor M; Moloney MK; Soltow QA; Webb PJ; Shaw KJ
Bioorg Med Chem Lett; 2019 Dec; 29(23):126713. PubMed ID: 31668974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
